{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52690"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52690","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"TOWARDS AN INSECT BRAIN-BASED BIOELECTRONIC NEURAL SENSOR FOR DISEASE DETECTION","abstract":"Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Sanchez, Simon W"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Saha, Debajit","Fazleabas, Asgerally T","Contag, Christopher H","Robison, Alfred J"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T18:59:26Z","subjects":["Biomedical engineering","Neurosciences"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52690","local:Sanchez_grad.msu_0128D_21659"],"render_values":[{"text":"etd:52690","href":null,"code":true},{"text":"local:Sanchez_grad.msu_0128D_21659","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/yv83-7x46","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/yv83-7x46","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52690","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Saha, Debajit","Fazleabas, Asgerally T","Contag, Christopher H","Robison, Alfred J"]},{"key":"dc:creator","label":"Author","values":["Sanchez, Simon W"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biomedical engineering","Neurosciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52690","local:Sanchez_grad.msu_0128D_21659","https://doi.org/doi:10.25335/yv83-7x46"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2025","Health screening is an effective and widely accepted practice in healthcare and tools that can prevent or detect diseases at an early stage can potentially increase survival rates, improve long term quality of life, and reduce treatment costs. Additionally, timely diagnosis can lead to clinical interventions that guide the treatment of therapies. For the timely diagnosis to occur, diagnostic tools are needed to detect changes in biological fluids at a high sensitivity and specificity for patients with the disease. Despite several clinical and laboratory-based tests, diagnosis and especially early diagnosis can still have limitations due to accuracies, methodological restrictions, invasive procedures, sampling protocols, personnel skillsets, and time to diagnosis. Here we discuss the detection of two diseases associated with some of these limitations: endometriosis and lung cancer. Endometriosis is a chronic gynecological disease characterized by the presence of ectopic endometrial-like tissue outside the uterus. This inflammatory disease affects approximately 10% of women of reproductive age and is clinically associated with a range of symptoms that are common to other gynecological and non-gynecological disorders. Women with endometriosis experience a substantial decrease in quality of life and the financial and emotional burden of endometriosis is amplified by the diagnostic delay which ranges from 4 to 11 years. Barriers to the early diagnosis and treatment of endometriosis are a result of the current standard of surgical diagnosis via a diagnostic laparoscopy with histological verification to confirm the presence of endometriotic glands and stroma. Thus, a shift from surgical diagnosis to a clinical one is imperative and should be explored. Lung cancer is the second highest commonly diagnosed cancer in the world and is the predominate cause of cancer-related death for both women and men. Currently, the most promising approach for lung cancer screening is with low dose computed tomography in high-risk populations which have shown to provide statistically significant mortality reduction in patients. This approach, however, relies on risk modeling methodology to select high-risk populations and to minimize the potential damages to radiation exposure to a broader population. Further, lung cancer can be divided into two main types, (1) small cell lung cancer (SCLC) and (2) non-small cell lung cancer (NSCLC). The most common subtype of lung cancer is NSCLC and is often detected after it has already spread to other organs. Screening and early detection of NSCLC play an important role in receiving a more favorable long-term prognosis. One proposed avenue for the screening and detection of diseases is through the use of volatile organic compounds (VOCs). VOCs are carbon-based chemicals that vaporize readily due to their chemical characteristics. VOCs are also emitted from the human body via exhaled breath and other biological fluids. It is thought that the composition and concentrations of VOCs are altered due to metabolic processing which could be influenced when the body is in a diseased state. It has been shown previously that the presence of several disease including cancer changes the VOC headspace above in vitro cultured cells. Differences in VOC concentrations have also been found in the breath of cancer patients in comparison to control groups. For systemic and complex diseases, a chemical gas sensor that can generalize and differentiate subtle differences in mixtures of VOCs is essential. Biological systems have solved the problem of chemical sensing via evolution and have converged to a solution that is architecturally and operationally similar across species. This signifies that there might be a superior solution for gas sensing that is still inaccessible from an engineering standpoint. Living organisms use biological olfaction to detect VOC mixtures via their robust odor recognition capabilities and generalization for chemicals which can be employed for disease detection. This work addresses the potential of using VOCs for disease detection by harnessing the chemosensory array and coding mechanisms of biological olfaction and combing it with both electronic and computation techniques for neural recording and odor classification. This sensor was applied for the detection and differentiation of endometriotic and lung cancer cell culture models including multiple types of cells (i.e., epithelial vs stromal) and disease subtypes (SCLC vs NSCLC). By analyzing the cell culture headspace-evoked neural responses, we show that our sensor can distinguish multiple cell lines by their ‘scent’ (i.e., emitted VOC mixture). Further, by combining neural responses across experiments, we obtained high-dimensional population neural response templates that were used to classify unknown samples with a high accuracy. We obtained an accuracy of 89% in differentiating 4 endometriotic cell lines at two growth timepoints (24 hr. and 72 hr.) and obtained an accuracy of 88% in classifying epithelial co-cultures of endometriotic and endometrial cell lines cultured at 0%, 25%, 50%, 75%, and 100% in ascending/descending ratios. Moreover, when used to detect and differentiate lung cancer and its subtypes we achieved a classification accuracy of 85 %. By integrating a biological sensory system with electronic and computation techniques, this work introduces a novel approach for endometriosis and lung cancer detection and moves toward a VOC-based disease screening method that can offer an accessible and precise disease diagnosis.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (172 p.) : ill."]},{"key":"dc:title","label":"Title","values":["TOWARDS AN INSECT BRAIN-BASED BIOELECTRONIC NEURAL SENSOR FOR DISEASE DETECTION"]}]}],"canonical_facts":{"dc:contributor":["Saha, Debajit","Fazleabas, Asgerally T","Contag, Christopher H","Robison, Alfred J"],"dc:creator":["Sanchez, Simon W"],"dc:date":["2025"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2025","Health screening is an effective and widely accepted practice in healthcare and tools that can prevent or detect diseases at an early stage can potentially increase survival rates, improve long term quality of life, and reduce treatment costs. Additionally, timely diagnosis can lead to clinical interventions that guide the treatment of therapies. For the timely diagnosis to occur, diagnostic tools are needed to detect changes in biological fluids at a high sensitivity and specificity for patients with the disease. Despite several clinical and laboratory-based tests, diagnosis and especially early diagnosis can still have limitations due to accuracies, methodological restrictions, invasive procedures, sampling protocols, personnel skillsets, and time to diagnosis. Here we discuss the detection of two diseases associated with some of these limitations: endometriosis and lung cancer. Endometriosis is a chronic gynecological disease characterized by the presence of ectopic endometrial-like tissue outside the uterus. This inflammatory disease affects approximately 10% of women of reproductive age and is clinically associated with a range of symptoms that are common to other gynecological and non-gynecological disorders. Women with endometriosis experience a substantial decrease in quality of life and the financial and emotional burden of endometriosis is amplified by the diagnostic delay which ranges from 4 to 11 years. Barriers to the early diagnosis and treatment of endometriosis are a result of the current standard of surgical diagnosis via a diagnostic laparoscopy with histological verification to confirm the presence of endometriotic glands and stroma. Thus, a shift from surgical diagnosis to a clinical one is imperative and should be explored. Lung cancer is the second highest commonly diagnosed cancer in the world and is the predominate cause of cancer-related death for both women and men. Currently, the most promising approach for lung cancer screening is with low dose computed tomography in high-risk populations which have shown to provide statistically significant mortality reduction in patients. This approach, however, relies on risk modeling methodology to select high-risk populations and to minimize the potential damages to radiation exposure to a broader population. Further, lung cancer can be divided into two main types, (1) small cell lung cancer (SCLC) and (2) non-small cell lung cancer (NSCLC). The most common subtype of lung cancer is NSCLC and is often detected after it has already spread to other organs. Screening and early detection of NSCLC play an important role in receiving a more favorable long-term prognosis. One proposed avenue for the screening and detection of diseases is through the use of volatile organic compounds (VOCs). VOCs are carbon-based chemicals that vaporize readily due to their chemical characteristics. VOCs are also emitted from the human body via exhaled breath and other biological fluids. It is thought that the composition and concentrations of VOCs are altered due to metabolic processing which could be influenced when the body is in a diseased state. It has been shown previously that the presence of several disease including cancer changes the VOC headspace above in vitro cultured cells. Differences in VOC concentrations have also been found in the breath of cancer patients in comparison to control groups. For systemic and complex diseases, a chemical gas sensor that can generalize and differentiate subtle differences in mixtures of VOCs is essential. Biological systems have solved the problem of chemical sensing via evolution and have converged to a solution that is architecturally and operationally similar across species. This signifies that there might be a superior solution for gas sensing that is still inaccessible from an engineering standpoint. Living organisms use biological olfaction to detect VOC mixtures via their robust odor recognition capabilities and generalization for chemicals which can be employed for disease detection. This work addresses the potential of using VOCs for disease detection by harnessing the chemosensory array and coding mechanisms of biological olfaction and combing it with both electronic and computation techniques for neural recording and odor classification. This sensor was applied for the detection and differentiation of endometriotic and lung cancer cell culture models including multiple types of cells (i.e., epithelial vs stromal) and disease subtypes (SCLC vs NSCLC). By analyzing the cell culture headspace-evoked neural responses, we show that our sensor can distinguish multiple cell lines by their ‘scent’ (i.e., emitted VOC mixture). Further, by combining neural responses across experiments, we obtained high-dimensional population neural response templates that were used to classify unknown samples with a high accuracy. We obtained an accuracy of 89% in differentiating 4 endometriotic cell lines at two growth timepoints (24 hr. and 72 hr.) and obtained an accuracy of 88% in classifying epithelial co-cultures of endometriotic and endometrial cell lines cultured at 0%, 25%, 50%, 75%, and 100% in ascending/descending ratios. Moreover, when used to detect and differentiate lung cancer and its subtypes we achieved a classification accuracy of 85 %. By integrating a biological sensory system with electronic and computation techniques, this work introduces a novel approach for endometriosis and lung cancer detection and moves toward a VOC-based disease screening method that can offer an accessible and precise disease diagnosis.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (172 p.) : ill."],"dc:identifier":["etd:52690","local:Sanchez_grad.msu_0128D_21659","https://doi.org/doi:10.25335/yv83-7x46"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Biomedical engineering","Neurosciences"],"dc:title":["TOWARDS AN INSECT BRAIN-BASED BIOELECTRONIC NEURAL SENSOR FOR DISEASE DETECTION"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:26Z"}